PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Principal Investigator
Daniel Landi, MD
Neuro-oncologist
Protocol Number
IRB:
PRO00109073
NCT:
NCT04323046
Phase
Phase
Pilot
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-684-5301